A new study suggests that low-grade prostate cancer in a significant number of cases will not become aggressive with time, reaffirming that active surveillance is an appropriate approach.
Harvard researchers found that after the introduction of widespread PSA screening, the proportion of patients diagnosed with advanced-stage cancers dropped by more than sixfold in 22 years, but the proportion diagnosed with high Gleason grade cancers did not change substantially.
Continue Reading
John Schieszer has the story in today’s Medical Minute.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.